Workflow
agilon health(AGL)
icon
Search documents
agilon health Provides 2023 Guidance Update, Initial 2024 View
Businesswire· 2024-01-05 11:00
AUSTIN, Texas--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced revised guidance expectations for 2023, reflecting higher-than-expected costs, and provided an initial outlook for 2024. During 2023, agilon health experienced an increase in medical expenses attributable to higher-than-expected specialist visits, Part B drugs, outpatient surgeries, and supplemental benefits, partially offset by lower hospital med ...
agilon health(AGL) - 2023 Q3 - Earnings Call Transcript
2023-11-06 00:51
Start Time: 16:30 January 1, 0000 5:29 PM ET agilon health, inc. (NYSE:AGL) Q3 2023 Earnings Conference Call November 02, 2023, 16:30 PM ET Company Participants Steve Sell - CEO Tim Bensley - CFO Matthew Gillmor - VP, IR Conference Call Participants Lisa Gill - JPMorgan Justin Lake - Wolfe Research Stephen Baxter - Wells Fargo Gary Taylor - Cowen Jailendra Singh - Truist Securities George Hill - Deutsche Bank Whit Mayo - Leerink Partners Adam Ron - Bank of America Jamie Perse - Goldman Sachs Elizabeth Ander ...
agilon health(AGL) - 2023 Q3 - Quarterly Report
2023-11-01 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _______________________________________________________ FORM 10-Q _______________________________________________________ (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the quarterly period ended September 30, 2023 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-40332 _____ ...
agilon health(AGL) - 2023 Q2 - Earnings Call Transcript
2023-08-04 20:27
agilon health, inc. (NYSE:AGL) Q2 2023 Earnings Conference Call August 3, 2023 4:30 PM ET Company Participants Matthew Gillmor - Vice President, Investor Relations Steve Sell - Chief Executive Officer Tim Bensley - Chief Financial Officer Conference Call Participants Lisa Gill - JPMorgan Jailendra Singh - Truist Securities Stephen Baxter - Wells Fargo Securities Gary Taylor - Cowen Whit Mayo - Leerink Partners Adam Ron - Bank of America George Hill - Deutsche Bank Sandy Draper - Guggenheim Securities Jamie ...
agilon health(AGL) - 2023 Q2 - Quarterly Report
2023-08-02 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _______________________________________________________ FORM 10-Q _______________________________________________________ (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the quarterly period ended June 30, 2023 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-40332 __________ ...
agilon health(AGL) - 2023 Q1 - Earnings Call Transcript
2023-05-13 23:43
agilon health, inc. (NYSE:AGL) Q1 2023 Results Conference Call May 9, 2023 4:30 PM ET Company Participants Matthew Gillmor - VP, IR Steve Sell - CEO Tim Bensley - CFO Conference Call Participants Lisa Gill - JPMorgan George Hill - Deutsche Bank Ryan Daniels - William Blair Justin Lake - Wolfe Research Carol Wong - Wells Fargo Securities Jailendra Singh - Truist Adam Ron - Bank of America Sean Dodge - RBC Capital Markets Ben Mayo - SVB Securities Jamie Perse - Goldman Sachs Gary Taylor - Cowen David Larsen - ...
agilon health(AGL) - 2023 Q1 - Quarterly Report
2023-05-08 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-40332 agilon health, inc. (Exact name of registrant as specified in its charter) Delaware 37-1915147 (State or other jurisdicti ...
agilon health(AGL) - 2022 Q4 - Earnings Call Transcript
2023-03-02 03:45
agilon health, Inc. (NYSE:AGL) Q4 2022 Results Conference Call March 1, 2022 4:30 PM ET Company Participants Matthew Gillmor - VP, IR Steve Sell - CEO Tim Bensley - CFO Conference Call Participants Sandy Draper - Guggenheim Whit Mayo - SVB Securities Brian Tanquilut - Jefferies David Larsen - BTIG George Hill - Deutsche Bank Jamie Perse - Goldman Sachs Justin Lake - Wolfe Research Kevin Fischbeck - Bank of America Lisa Gill - JP Morgan Ryan Daniels - William Blair Sean Dodge - RBC Stephen Baxter - Wells Fa ...
agilon health(AGL) - 2022 Q4 - Annual Report
2023-02-28 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the fiscal year ended December 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-40332 agilon health, inc. (Exact name of registrant as specified in its charter) Delaware 37-1915147 (State or other jurisdiction of ...
agilon health(AGL) - 2022 Q3 - Earnings Call Transcript
2022-11-05 23:19
agilon health, inc. (NYSE:AGL) Q3 2022 Results Conference Call November 3, 2022 5:00 PM ET Company Participants Matthew Gillmor - VP, IR Steve Sell - CEO Tim Bensley - CFO Conference Call Participants Lisa Gill - JP Morgan Justin Lake - Wolfe Research Adam Ron - Bank of America Ryan Daniels - William Blair Whit Mayo - SVB Securities Sean Dodge - RBC Capital Markets Taji Phillips - Jefferies Stephen Baxter - Wells Fargo Jamie Perse - Goldman Sachs Gary Taylor - Cowen Operator Hello, and a warm welcome to tod ...